Zhaohui Wang

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Multidrug Resistant

Metastatic Colorectal Cancer

Top Venues

Science advances

Molecular cancer therapeutics

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Weining Weng, Tao Meng, Qianqian Zhao, Yi Shen, Guoxiang Fu, Jing Shi, Yue Zhang, Zhaohui Wang, Mingqiao Wang, Rong Pan, Linjie Ma, Caiwei Chen, Lijun Wang, Biao Zhou, Hui Zhang, Junyi Pu, Jianjian Zhang, Yi Peter Hu, Guoqiang Hua, Yu Qian, Shu-Hui Liu, Wen-Hao Hu, Xun Meng
Antibody-exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer. Cancer discovery (2023)
Weining Weng, Tao Meng, Junyi Pu, Linjie Ma, Yi Shen, Zhaohui Wang, Rong Pan, Mingqiao Wang, Caiwei Chen, Lijun Wang, Jianjian Zhang, Biao Zhou, Siyuan Shao, Yu Qian, Shu-Hui Liu, Wen-Hao Hu, Xun Meng
AMT-562, a novel HER3-targeting antibody drug conjugate, demonstrates a potential to broaden therapeutic opportunities for HER3-expressing tumors. Molecular cancer therapeutics (2023)
Zhaohui Wang, Yang Li, Bing Hou, Mira I Pronobis, Mingqiao Wang, Yuemeng Wang, Guangcun Cheng, Weining Weng, Yiqiang Wang, Yanfang Tang, Xuefan Xu, Rong Pan, Fei Lin, Nan Wang, Ziqing Chen, Shiwei Wang, Luyan Zulie Ma, Yang-Rui Li, Dong-Liang Huang, Li Jiang, Zhiqiang Wang, Wenfang Zeng, Ying Zhang, Xuemei Du, Ying Lin, Zhiqing Li, Qingyou Xia, Jing Geng, Huaping Dai, Yuan Yu, Xiao-Dong Zhao, Zheng Yuan, Jian Yan, Qinghua Nie, Xiquan Zhang, Kun Wang, Fulin Chen, Qin Zhang, Yuxian Zhu, Susan Zheng, Kenneth D Poss, Sheng-Ce Tao, Xun Meng
An array of 60,000 antibodies for proteome-scale antibody generation and target discovery. Science advances 6 (11) (2020)